Impedance-Based Cell Response Profiling for Oncogene Inhibitor Screening
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for screening and identifying inhibitors for oncogenes and their pathways are limited by their reliance on endpoint assays, which do not distinguish between temporal modulation of oncogene pathways and other pathways, and require extensive manipulations like washing, fixation, and staining.
Innovation Solution
The development of an impedance-based cell response profiling approach that monitors real-time cellular responses to biologically active agents in oncogene-addicted cells, allowing for the identification of unique time-dependent cellular profiles (TCRPs) that are specific to oncogene inhibition, without the need for reporter proteins or extensive manipulations.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If endpoint assays are used to screen inhibitors, then the assay procedure is simple, but the ability to distinguish temporal modulation of oncogene pathways is lost and extensive manipulations are required
Solution Approach 1:
The patent replaces traditional mechanical/chemical endpoint assays with an electrical impedance-based measurement system. The xCelligence RT-CES system uses interdigitated electrodes to continuously monitor cell-substrate impedance, substituting complex wet lab manipulations (washing, fixation, staining) with automated electrical measurements that provide real-time data on cellular responses to oncogene inhibition.
Solution Approach 2:
The invention implements continuous monitoring of cellular responses through real-time impedance measurements taken at multiple time points (e.g., every 15 minutes for 240 hours). This continuous data collection captures the temporal dynamics of oncogene pathway modulation, allowing distinction between transient and sustained effects that endpoint assays cannot detect.
2Measurement precision
If endpoint assays with washing and fixation are used, then the measurement is straightforward, but time-consuming manipulations are required
Solution Approach 1:
The impedance-based system requires no manual washing, fixation, or staining steps. The cells continuously adhere to the electrode-coated substrate and provide spontaneous electrical signals that reflect their physiological state. The system serves itself by automatically recording impedance changes without requiring researcher intervention for sample preparation or processing between measurements.
Solution Approach 2:
The system performs uninterrupted real-time measurements throughout the entire assay period, eliminating the sequential time-consuming steps of traditional endpoint assays. Impedance data is continuously recorded without removing cells from the culture medium or performing intermediate manipulations, drastically reducing total assay time while maintaining measurement quality.
3Productivity
If traditional screening methods are used, then the protocol is established, but the ability to capture short and long-term cellular responses is limited
Solution Approach 1:
The invention adds a temporal dimension to traditional screening by collecting impedance data across multiple time points (e.g., 0, 24, 48, 72, 168, 240 hours). This transforms the assay from a single endpoint measurement into a time-resolved profile, enabling identification of unique temporal patterns (signatures) that distinguish oncogene-specific inhibition from other cellular responses.
Solution Approach 2:
The system uses real-time impedance feedback to monitor cellular responses dynamically. By continuously measuring changes in cell-substrate impedance and comparing them against control profiles, the system automatically identifies compounds that produce unique temporal signatures indicative of oncogene pathway inhibition, enabling high-throughput screening with enhanced information content.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method enables the effective identification of small molecule inhibitors targeting oncogenes or oncogene pathways by generating unique impedance-based signatures, providing a more accurate and efficient means of cancer drug development by capturing both short and long-term cellular responses.
Implementation Method 1
impedance-based devices...monitors real-time cellular responses...generating unique impedance-based signatures
Data Source
AI summary
Use of impedance devices in methods of generating a time dependent cellular profiles (TCRP) for the modulation of oncogene addicted cells and comparing the impedance-based TCRP to controls or knowns to identify signature time dependent cellular profiles.